Keyword: products

Egis Pharmaceuticals Plc. Expands Its Portfolio with a Well-Known Product Line

Egis Pharmaceuticals has announced that, backed by the Hungarian Competition Authority´s official certification, it has acquired one of Hungary´s well-known, locally applied dermatological product lines from Teva Pharmaceutical Industries Ltd. This move aims to strengthen Egis´s position in the Hungarian over-the-counter (OTC) market.

More

Egis' medicines won the Innovation Grand Prize

Two of Egis’ fixed-dose combination drugs have won the Innovation Grand Prize. The awarded Egis medicines feature significant innovations as they reduce the risk of cardiovascular events related to atherosclerosis due to the combined lipid-lowering therapy. In respect of these two products the company obtained three patents related to active ingredient development and two patents related to formulation development that are all relevant to large-scale manufacturing technologies. The recognition was not without a history, as this is the tenth time an Egis medicine has received an Innovation Prize or Grand Prize.

More

Egis as a special partner at one of the biggest professional events of the year for pharmacists

Once again, Egis was a Gold Exhibitor at the grandExpo, an event with more than two thousand invitees.

More

New Unit Inaugurated at Egis’s Körmend Plant

Egis and our consortia partners have won 2,332 billion HUF direct grant in the framework of the innovation tender GINOP-2.2.1-15-2016-00023 for the realisation of the above-mentioned project.

More

Egis strengthens presence in Russia by OTC acquisition

Hungarian-based Egis Pharmaceuticals acquired D-Panthenol and women’s health product portfolio from Jadran-Galenski Laboratorij’s (JGL). The company intends to further strengthen its position in major export markets, via select acquisitions.

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox
Lightbox Image